Table 2.

Direct medical costs of bladder cancer in terms of diagnostic and treatment procedures in Iran (2018)

Stage	Cost ($)
	White-light-guided TURBT (including patology, visit, drug, …)	Intravesical mitomycin C	Urologist visit	BCG therapy	Imaging & Lab services	Radical cystectomy	Chemotherapy& radiotherapy	Total
Ta low	2,556,120	154,564	134,128	0.00	1,027,200	0.00	0.00	3,872,013
Ta High	1,278,060	0.00	44,106	1,090,376.86	422,090	0.00	0.00	2,834,633
T1	1,825,800	0.00	57,185	1,479,149.19	549,481	0.00	0.00	3,911,615
CIS	456,450	0.00	27,290	722,494.61	263,628	0.00	0.00	1,469,863
NMIBC recurrent	2,246,918	119,690	72,007	1,117,765.53	618,192	0.00	0.00	4,174,573
T2–T3	418,141	0.00	88,783	0.00	1,144,568	5,728,305	1,125,251	8,505,048
Metastases	105,407	0.00	59,837	0.00	820,590	0.00	2,904,332	3,890,166
Total	8,886,896	274,254	483,337	4,409,786.19	4,845,749	5,728,305	4,029,583	28,657,910
Percent of total	31.01	0.96	1.69	15.39	16.91	19.99	14.06	100.00